Need Help? Chat Now With a Live Representative!

Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

March 1, 2023

CHARLOTTESVILLE, Va., March 1, 2023 -- Jeffrey H. Lawson, MD, PhD has joined Atlantic Research Group (ARG) as Chief Medical Officer. 

The arrival of Dr. Lawson will combine his extensive clinical, scientific and business experience with ARG’s operational expertise to address the unmet need for better design, management and execution of interventional, surgical and acute care studies. 

Dr. Lawson brings extensive expertise in protocol design, operative proctoring, post procedure events, data collection and interventional adverse events. He serves as adjunct professor of Surgery and Pathology at Duke University, where he has also previously acted as Vice Chair of Research, overseeing all Duke surgery clinical research and over 400 studies.

“I am excited about the opportunity at ARG. Having worked with their operational group in the past, I know firsthand that they know how to get challenging and important studies done,” said Dr. Lawson. He added: “By coming on board, we can really focus on accelerating the number and sophistication of surgical studies to bring new technologies to market and new solutions to patients.”

ARG, founded in 2004, already an industry leader in clinical trial management in surgery, oncology, immunology and neurology, has a proven track record of operational expertise including trauma, vascular bypass and transplant, both nationally and internationally.

CEO Paul Bishop stated, “We are really pleased to have Jeff join us. His clinical and scientific experience speaks for itself, but he also has an impressive track record as a business leader. In addition, Jeff is deeply respected as a Key Opinion Leader (KOL) and has access to a network of interventional experts. All of this combined with our existing capabilities will help us serve the objectives of our clients.”

Dr. Lawson was previously CEO of both Humacyte (HUMA:Nasdaq) and InnAVasc (recently acquired by W.L. Gore) and is currently a Board Member of the Kidney Health Initiative (KHI). 

Please find a download of the release here.

ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

CHARLOTTESVILLE, Va., April 11, 2023 — Victoria Allgood, PhD, has joined Atlantic Research Group (ARG) as Vice President, Scientific Affairs, […]

April 11, 2023
Atlantic Research Group Opens Office in Munich

Atlantic Research Group Opens Office in Munich

CHARLOTTESVILLE, Va. and MUNICH, June 8, 2022 — Atlantic Research Group (ARG), a full-service global contract research organization (CRO), has […]

June 7, 2022
ARG One of 16 Companies Selected to Participate in Virginia Trade Program

ARG One of 16 Companies Selected to Participate in Virginia Trade Program

The Virginia Economic Development Partnership (VEDP) recently announced in a press release the “acceptance of 16 companies into its two-year […]

January 19, 2022
GO TO TOP